Actionable news
All posts from Actionable news
Actionable news in SRNE: Sorrento Therapeutics, Inc.,

Entry into a Material Definitive

Option Agreement

On October14, 2015, Sorrento Therapeutics, Inc. (the Company) entered into an option agreement with Cambridge Equities, LP (Cambridge) pursuant to which the Company granted to Cambridge an unconditional, irrevocable option (the Option) to purchase up to 2,000,000 shares of NantKwest, Inc. common stock owned by the Company at a price of $15.295 per share. The Option is exercisable for the period beginning on January1, 2016 and ending March31, 2016.

The foregoing summary is qualified in its entirety by reference to the Option Agreement, a copy of which will be attached as an exhibit to the Companys Annual Report on Form 10-K for the...